Regulatory clarity for drug–device and integrated combination products.
Combination products include a combination of a medical device, and a drug (and/or biologic – only US). This module aims to provide participants with knowledge of the regulatory requirements for each component of a combination product including their similarities and differences. It will additionally provide participants with an understanding of combination product market launch considerations.
On-site (in-person) events:
- 30.04.2026 (9-4pm) - Kickoff
- 10.06.2026 (9-4pm) - Wrap up and industry case study
These dates might be subject to change
In between those two onsite events you will have access to our online learning-platform with extensive individual learning opportunities.
